Expression mapping of ectonucleotide pyrophosphatase/phosphodiesterase 1-3 (E-NPP1-3) in different brain structures during rat development

被引:15
作者
Cognato, Giana de Paula [2 ]
Czepielewski, Rafael Sanguinetti [1 ]
Freitas Sarkis, Joao Jose [2 ]
Bogo, Mauricio Reis [3 ]
Bonan, Carla Denise [1 ]
机构
[1] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Dept Biodiversidade, Lab Biol Genom & Mol, BR-9061900 Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande do Sul, Dept Bioquim, Porto Alegre, RS, Brazil
[3] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Dept Biol Celular & Mol, Lab Neuroquim & Psicofarmacol, BR-9061900 Porto Alegre, RS, Brazil
关键词
developing brain; E-NPP; LPA; autotoxin; purinergic signaling; ATP;
D O I
10.1016/j.ijdevneu.2008.05.001
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Ecto-nucleotide pyrophosphatases/phosphodiesterases (E-NPPs) are membrane-bound ecto-enzymes involved in the modulation of purinergic signaling. Important physiological roles related to brain development have been associated to purinergic neurotransmission. NPP1, two splice isoforms of NPP2, and NPP3 have already been identified in adult rat brain. However, there are no studies evaluating the mRNA expression of these NPP members during the brain development. The effort of the present study was to map NPP gene expression pattern in olfactory bulb, hippocampus, cerebral cortex, striatum, and cerebellum at crucial ages for rat development (7, 14, 21, 60, and 150 days old) by a semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) strategy. Our results demonstrated an increase in the relative expression of NPP1 throughout the aging in all structures analyzed, except in hippocampus, where the higher expression has been detected in 14 days old rats. Both NPP2 isoforms have shown a similar pattern of expression among all structures. The relative expression of NPP3 decreased during the aging mainly on cerebellum, hippocampus, and olfactory bulb. Altogether, the different patterns of NPP gene expression during rat brain development reinforce the idea that each enzyme may play a distinct role on modulating the purinergic signaling throughout aging. (C) 2008 ISDN. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:593 / 598
页数:6
相关论文
共 28 条
[1]   Immunolocalization of ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) in the rat forebrain [J].
Bjelobaba, Ivana ;
Nedeljkovic, Nadezda ;
Subasic, Sanja ;
Lavrnja, Irena ;
Pekovic, Sanja ;
Stojkov, Danijela ;
Rakic, Ljubisav ;
Stojiljkovic, Mirjana .
BRAIN RESEARCH, 2006, 1120 :54-63
[2]  
BlassKampmann S, 1997, J NEUROSCI RES, V48, P95, DOI 10.1002/(SICI)1097-4547(19970415)48:2<95::AID-JNR2>3.0.CO
[3]  
2-7
[4]   Nucleotide pyrophosphatases/phosphodiesterases on the move [J].
Bollen, M ;
Gijsbers, R ;
Ceulemans, H ;
Stalmans, W ;
Stefan, C .
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2000, 35 (06) :393-432
[5]   Physiology and pathophysiology of purinergic neurotransmission [J].
Burnstock, Geoffrey .
PHYSIOLOGICAL REVIEWS, 2007, 87 (02) :659-797
[6]   Enhancement of spontaneous synaptic activity in rat Purkinje neurones by ATP during development [J].
Casel, D ;
Brockhaus, J ;
Deitmer, JW .
JOURNAL OF PHYSIOLOGY-LONDON, 2005, 568 (01) :111-122
[7]   Substrate-specifying determinants of the nucleotide pyrophosphatases/phosphodiesterases NPP1 and NPP2 [J].
Cimpean, A ;
Stefan, C ;
Gijsbers, R ;
Stalmans, W ;
Bollen, M .
BIOCHEMICAL JOURNAL, 2004, 381 :71-77
[8]   P2YAC- -receptor agonists enhance the proliferation of rat C6 glioma cells through activation of the p42/44 mitogen-activated protein kinase [J].
Claes, P ;
Grobben, B ;
Van Kolen, K ;
Roymans, D ;
Slegers, H .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (02) :402-408
[9]   Antiepileptic drugs prevent changes induced by pilocarpine model of epilepsy in brain ecto-nucleotidases [J].
Cognato, Giana de Paula ;
Bruno, Alessandra Nejar ;
da Silva, Rosane Souza ;
Bogo, Mauricio Reis ;
Freitas Sarkis, Joao Jose ;
Bonan, Carla Denise .
NEUROCHEMICAL RESEARCH, 2007, 32 (06) :1046-1055
[10]  
FREDHOLM BB, 1994, PHARMACOL REV, V46, P143